<html><head><meta name="qrichtext" content="charset=utf-8" /></head><body style="font-size:10pt;font-family:Sans">
<p>&nbsp;<br /><br /></p>
<p align="center"><span style="font-weight:600;text-decoration:underline">CAT&nbsp;DEVANT&nbsp;UN&nbsp;AVC</span><br /></p>
<p><br />TOUJOURS&nbsp;RECHERCHER&nbsp;UNE&nbsp;HYPOGLYCEMIE&nbsp;=&gt;&nbsp;DEXTRO&nbsp;+++<br />TOUJOURS&nbsp;Y&nbsp;REFLECHIR&nbsp;A&nbsp;DEUX&nbsp;FOIS&nbsp;AVANT&nbsp;DE&nbsp;TRAITER&nbsp;UNE&nbsp;HTA<br /><br />Tous&nbsp;les&nbsp;patients&nbsp;présentant&nbsp;un&nbsp;AVC&nbsp;(ou&nbsp;pathologie&nbsp;neurologique&nbsp;aiguë&nbsp;en&nbsp;général)&nbsp;doivent&nbsp;pouvoir&nbsp;bénéficier&nbsp;d'un&nbsp;scanner&nbsp;en&nbsp;urgence.<br /><br />L'accés&nbsp;à&nbsp;cet&nbsp;examen&nbsp;doit&nbsp;cependant&nbsp;ëtre&nbsp;&nbsp;hiérarchisé&nbsp;en&nbsp;fonction&nbsp;des&nbsp;conséquences&nbsp;thérapeutiques&nbsp;immédiates:<br />-&nbsp;décision&nbsp;d'une&nbsp;anticoagulation&nbsp;(cf&nbsp;ci-dessous)<br />-&nbsp;chirurgie&nbsp;(sous-dural,&nbsp;anévrysme&nbsp;artériel,&nbsp;malformation&nbsp;artério-veineuse)<br />-&nbsp;traitement&nbsp;antibiotique:&nbsp;encéphalite,&nbsp;patient&nbsp;HIV&nbsp;(Toxoplasmose,Abcés??)<br /><br /><span style="font-weight:600">TRAITEMENTS</span>&nbsp;<span style="font-weight:600">:<br /></span><br /><span style="font-weight:600;text-decoration:underline">1)&nbsp;CONTROLE&nbsp;DE&nbsp;LA&nbsp;TA</span><br /><span style="font-weight:600">&gt;&nbsp;Qui</span>&nbsp;<span style="font-weight:600">traiter?</span><br />·&nbsp;Les&nbsp;patients&nbsp;conservant&nbsp;une&nbsp;TA&nbsp;<span style="text-decoration:underline">&gt;</span>&nbsp;&nbsp;23/13&nbsp;contrôlée&nbsp;à&nbsp;30&nbsp;minotes<br /><span style="font-weight:600">&gt;&nbsp;Comment?</span><br />·&nbsp;Traitement&nbsp;prudent&nbsp;et&nbsp;progressif&nbsp;=&gt;&nbsp;<span style="font-weight:600">Adalate&nbsp;sublingual&nbsp;INTERDIT</span><br />·&nbsp;Traitement&nbsp;IV&nbsp;de&nbsp;préférence&nbsp;(Eupressyl,&nbsp;Loxen),&nbsp;débuté&nbsp;à&nbsp;petites&nbsp;doses&nbsp;sans&nbsp;bolus<br />·&nbsp;Traitement&nbsp;encore&nbsp;plus&nbsp;prudent&nbsp;si&nbsp;patient&nbsp;agé&nbsp;ou&nbsp;hypertendu&nbsp;connu<br />·&nbsp;AVC&nbsp;Ischémique&nbsp;		=&gt;&nbsp;conserver&nbsp;TA&nbsp;entre&nbsp;180&nbsp;et&nbsp;220mmHg&nbsp;de&nbsp;systolique<br />·&nbsp;AVG&nbsp;Hémorragique&nbsp;	=&gt;&nbsp;conserver&nbsp;TA&nbsp;entre&nbsp;150&nbsp;et&nbsp;180mmHg&nbsp;de&nbsp;systolique<br /><br /><span style="font-weight:600;text-decoration:underline">2)&nbsp;ASPIRINE</span><br /><span style="font-weight:600">&gt;&nbsp;Qui</span>&nbsp;<span style="font-weight:600">traiter?</span><br />Tous&nbsp;les&nbsp;patients&nbsp;en&nbsp;I'absence&nbsp;de&nbsp;contre&nbsp;indications,&nbsp;si&nbsp;scanner&nbsp;normal&nbsp;ou&nbsp;AVC&nbsp;ischémique&nbsp;visible.<br />Peut&nbsp;être&nbsp;associé&nbsp;à&nbsp;I'hépanne<br /><span style="font-weight:600">&nbsp;&gt;&nbsp;Comment?</span><br />300&nbsp;mg&nbsp;IV&nbsp;puis&nbsp;250&nbsp;mg/jour&nbsp;per&nbsp;os<br /><br /><span style="font-weight:600;text-decoration:underline">3)&nbsp;+ANTICOAGULATION&nbsp;EN&nbsp;URGENCE</span><br /><span style="font-weight:600">&gt;&nbsp;Qul</span>&nbsp;<span style="font-weight:600">traiter?</span><br />·&nbsp;AIT&nbsp;survenant&nbsp;chez&nbsp;un&nbsp;patjent&nbsp;déjà&nbsp;sous&nbsp;antiaggrégant<br />·&nbsp;Cardiopathie&nbsp;emboligène&nbsp;(Fibrillation&nbsp;Auriculaire,&nbsp;RM,&nbsp;séquelles&nbsp;IDM...)<br />·&nbsp;Sténose&nbsp;carotidienne&nbsp;très&nbsp;serrée&nbsp;(ou&nbsp;dissection)&nbsp;=&gt;&nbsp;Doppler&nbsp;en&nbsp;urgence&nbsp;si&nbsp;possible<br />·&nbsp;Thrombose&nbsp;du&nbsp;tronc&nbsp;basilaire&nbsp;=&gt;&nbsp;artério&nbsp;en&nbsp;urgence&nbsp;=&gt;&nbsp;thrombolyse&nbsp;à&nbsp;discuter<br />	y&nbsp;penser&nbsp;si&nbsp;déficit&nbsp;bilatéral&nbsp;ou&nbsp;à&nbsp;bascule,&nbsp;nystagmus,&nbsp;Babinsky&nbsp;bilat,&nbsp;fluctuation&nbsp;de&nbsp;la&nbsp;	consclence<br />·&nbsp;Thrombophlébite&nbsp;cérébrale&nbsp;=&gt;&nbsp;artério&nbsp;ou&nbsp;IRM&nbsp;en&nbsp;urgence<br />y&nbsp;penser&nbsp;pour&nbsp;tous&nbsp;les&nbsp;AVC&nbsp;ischémiques&nbsp;&lt;&nbsp;45ans<br /><span style="font-weight:600">&gt;Comment?</span><br />·&nbsp;TOUJOURS&nbsp;après&nbsp;un&nbsp;scanner&nbsp;en&nbsp;urgence:&nbsp;normal&nbsp;ou&nbsp;AVC&nbsp;ischémique&nbsp;visible<br />·&nbsp;Héparine&nbsp;IV&nbsp;à&nbsp;la&nbsp;SE&nbsp;(Pas&nbsp;BHBPM!)&nbsp;=&gt;&nbsp;TCA&nbsp;=&nbsp;2&nbsp;à&nbsp;2,5&nbsp;x&nbsp;Témoin<br /><br /><span style="font-weight:600;text-decoration:underline">4)&nbsp;TROUBLES&nbsp;SEVERES&nbsp;DE&nbsp;LA&nbsp;CONSCIENCE:</span><br />Traitement&nbsp;anti-oedémateux:&nbsp;Mannitol&nbsp;20%&nbsp;en&nbsp;Y&nbsp;(100ml&nbsp;en&nbsp;10&nbsp;min&nbsp;/<span style="font-style:italic">&nbsp;</span>4&nbsp;heures)<br /><br /><span style="font-weight:600;text-decoration:underline">5)&nbsp;TRAITEMENTS&nbsp;SYMPTOMATIQUES</span><br />-02<br />-&nbsp;VV:<span style="font-weight:600">&nbsp;</span>Sérum<span style="font-weight:600">&nbsp;</span>Physiologique<span style="font-weight:600">&nbsp;</span>=1,5<span style="font-weight:600">&nbsp;</span>litres<br />=&gt;<span style="font-weight:600">&nbsp;</span>Si<span style="font-weight:600">&nbsp;</span>AVC<span style="font-weight:600">&nbsp;</span>ischémique<span style="font-weight:600">&nbsp;</span>prévoir<span style="font-weight:600">&nbsp;</span>au<span style="font-weight:600">&nbsp;</span>choix:<br />*&nbsp;REXORT<span style="font-weight:600">&nbsp;</span>250:<span style="font-weight:600">&nbsp;</span>3&nbsp;Amp<span style="font-weight:600">&nbsp;</span>IVD<span style="font-weight:600">&nbsp;</span>par<span style="font-weight:600">&nbsp;</span>jour<br />·&nbsp;TORENTAL<span style="font-weight:600">&nbsp;</span>300<span style="font-weight:600">&nbsp;</span>perfusion:<span style="font-weight:600">&nbsp;</span>3&nbsp;à&nbsp;4&nbsp;A&nbsp;qar<span style="font-weight:600">&nbsp;</span>jour<br />*&nbsp;NOOTROPYL<span style="font-weight:600">&nbsp;</span>1g<span style="font-weight:600">&nbsp;</span>perfusion:<span style="font-weight:600">&nbsp;</span>3A<span style="font-weight:600">&nbsp;</span>par<span style="font-weight:600">&nbsp;</span>lour<br /><br /><br /><span style="font-weight:600">SAU&nbsp;NORD&nbsp;Novembre&nbsp;1999</span><br /></p>
</body></html>
